|
L8051
|
6505-01-433-7369
|
Usp Sodium Chloride Injection |
Kendall Mcgaw
|
|
Quote
|
|
NDC00264-7805-10
|
6505-01-433-7369
|
Usp Sodium Chloride Injection |
Kendall Mcgaw
|
|
Quote
|
|
96-0478
|
6505-01-433-7370
|
Calcium Carbonate And Magnesium |
Defense Medical Standardization
|
|
Quote
|
|
NDC01683-7615-70
|
6505-01-433-7370
|
Calcium Carbonate And Magnesium |
Johnson and Johnson/merck
|
|
Quote
|
|
NDC00904-5115-71
|
6505-01-433-7370
|
Calcium Carbonate And Magnesium |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC16837-0849-70
|
6505-01-433-7370
|
Calcium Carbonate And Magnesium |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC00078-0179-15
|
6505-01-433-8677
|
Terbinafine Hydrochloride Tablet |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00078-0179-15
|
6505-01-433-8677
|
Terbinafine Hydrochloride Tablet |
Veterans Health
|
|
Quote
|
|
LAMISIL
|
6505-01-433-8677
|
Terbinafine Hydrochloride Tablet |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
96-0448
|
6505-01-433-8677
|
Terbinafine Hydrochloride Tablet |
Defense Logistics Agency
|
|
Quote
|
|
NDC00078-0179-15
|
6505-01-433-8677
|
Terbinafine Hydrochloride Tablet |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
PROCRIT
|
6505-01-433-8683
|
Erythropoietin Human Glycoform A |
Johnson & Johnson Sales And
|
|
Quote
|
|
96-0427
|
6505-01-433-8683
|
Erythropoietin Human Glycoform A |
Defense Logistics Agency
|
|
Quote
|
|
NDC59676-0310-01
|
6505-01-433-8683
|
Erythropoietin Human Glycoform A |
Johnson & Johnson Sales And
|
|
Quote
|
|
PROCRIT
|
6505-01-433-8684
|
Erythropoietin Human Glycoform A |
Johnson & Johnson Sales And
|
|
Quote
|
|
96-0426
|
6505-01-433-8684
|
Erythropoietin Human Glycoform A |
Defense Logistics Agency
|
|
Quote
|
|
NDC59676-0304-01
|
6505-01-433-8684
|
Erythropoietin Human Glycoform A |
Johnson & Johnson Sales And
|
|
Quote
|
|
PROCRIT
|
6505-01-433-8686
|
Erythropoietin Human Glycoform A |
Johnson & Johnson Sales And
|
|
Quote
|
|
96-0428
|
6505-01-433-8686
|
Erythropoietin Human Glycoform A |
Defense Logistics Agency
|
|
Quote
|
|
NDC59676-0312-01
|
6505-01-433-8686
|
Erythropoietin Human Glycoform A |
Johnson & Johnson Sales And
|
|
Quote
|
|
PROCRIT
|
6505-01-433-8690
|
Erythropoietin Human Glycoform A |
Johnson & Johnson Sales And
|
|
Quote
|
|
96-0424
|
6505-01-433-8690
|
Erythropoietin Human Glycoform A |
Defense Logistics Agency
|
|
Quote
|
|
NDC59676-0302-01
|
6505-01-433-8690
|
Erythropoietin Human Glycoform A |
Johnson & Johnson Sales And
|
|
Quote
|
|
NIMBEX
|
6505-01-434-0317
|
Cisatracurium Besylate Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
96-0435
|
6505-01-434-0317
|
Cisatracurium Besylate Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC00173-0546-00
|
6505-01-434-0317
|
Cisatracurium Besylate Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
96-0438
|
6505-01-434-0318
|
Glimepiride Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AMARYL
|
6505-01-434-0318
|
Glimepiride Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
NDC00039-0222-10
|
6505-01-434-0318
|
Glimepiride Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
NDC00039-0222-10
|
6505-01-434-0318
|
Glimepiride Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
PROCRIT
|
6505-01-434-0320
|
Erythropoietin Human Glycoform A |
Johnson & Johnson Sales And
|
|
Quote
|
|
96-0425
|
6505-01-434-0320
|
Erythropoietin Human Glycoform A |
Defense Logistics Agency
|
|
Quote
|
|
NDC59676-0303-01
|
6505-01-434-0320
|
Erythropoietin Human Glycoform A |
Johnson & Johnson Sales And
|
|
Quote
|
|
96-0441
|
6505-01-434-0321
|
Glimepiride Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AMARYL
|
6505-01-434-0321
|
Glimepiride Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
NDC00039-0223-11
|
6505-01-434-0321
|
Glimepiride Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
96-0436
|
6505-01-434-0322
|
Glimepiride Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AMARYL
|
6505-01-434-0322
|
Glimepiride Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
NDC63304-0427-01
|
6505-01-434-0322
|
Glimepiride Tablets |
Ranbaxy Pharmaceuticals Inc
|
|
Quote
|
|
NDC00039-0223-10
|
6505-01-434-0322
|
Glimepiride Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
96-0440
|
6505-01-434-0323
|
Glimepiride Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AMARYL
|
6505-01-434-0323
|
Glimepiride Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
NDC00039-0221-10
|
6505-01-434-0323
|
Glimepiride Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
PRECOSE
|
6505-01-434-0937
|
Acarbose Tablets |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
96-0413
|
6505-01-434-0937
|
Acarbose Tablets |
Defense Logistics Agency
|
|
Quote
|
|
16252052401
|
6505-01-434-0937
|
Acarbose Tablets |
Watson Pharmaceuticals Inc.
|
|
Quote
|
|
NDC16252-0524-01
|
6505-01-434-0937
|
Acarbose Tablets |
Watson Pharmaceuticals Inc.
|
|
Quote
|
|
CORMAX
|
6505-01-434-0938
|
Clobetasol Proprionate Topical S |
Oclassen Pharmaceuticals Inc
|
|
Quote
|
|
96-0418
|
6505-01-434-0938
|
Clobetasol Proprionate Topical S |
Defense Logistics Agency
|
|
Quote
|
|
NDC55515-0430-25
|
6505-01-434-0938
|
Clobetasol Proprionate Topical S |
Oclassen Pharmaceuticals Inc
|
|
Quote
|
|
NIMBEX
|
6505-01-434-0939
|
Cisatracurium Besylate Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
96-0433
|
6505-01-434-0939
|
Cisatracurium Besylate Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC00173-0540-50
|
6505-01-434-0939
|
Cisatracurium Besylate Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
CORMAX
|
6505-01-434-0940
|
Clobetasol Proprionate Topical S |
Oclassen Pharmaceuticals Inc
|
|
Quote
|
|
96-0419
|
6505-01-434-0940
|
Clobetasol Proprionate Topical S |
Defense Logistics Agency
|
|
Quote
|
|
NDC55515-0430-50
|
6505-01-434-0940
|
Clobetasol Proprionate Topical S |
Oclassen Pharmaceuticals Inc
|
|
Quote
|
|
NIMBEX
|
6505-01-434-0941
|
Cisatracurium Besylate Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
96-0434
|
6505-01-434-0941
|
Cisatracurium Besylate Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC00173-0543-01
|
6505-01-434-0941
|
Cisatracurium Besylate Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
96-0442
|
6505-01-434-1714
|
Mupirocin Ointment |
Defense Logistics Agency
|
|
Quote
|
|
NDC00029-1526-11
|
6505-01-434-1714
|
Mupirocin Ointment |
Veterans Health
|
|
Quote
|
|
NDC00029-1526-11
|
6505-01-434-1714
|
Mupirocin Ointment |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
BACTROBAN
|
6505-01-434-1714
|
Mupirocin Ointment |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
50419086251
|
6505-01-434-3410
|
Acarbose Tablets |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC50419-0862-51
|
6505-01-434-3410
|
Acarbose Tablets |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
96-0437
|
6505-01-434-3411
|
Glimepiride Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AMARYL
|
6505-01-434-3411
|
Glimepiride Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
NDC00039-0222-11
|
6505-01-434-3411
|
Glimepiride Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
DISTILLED WATER
|
6505-01-434-4936
|
Modified Purified Water |
Beatrice Foods Co
|
|
Quote
|
|
308
|
6505-01-434-4936
|
Modified Purified Water |
Beatrice Foods Co
|
|
Quote
|
|
96-0417
|
6505-01-434-7725
|
Saquinavir Mesylate Capsules |
Defense Logistics Agency
|
|
Quote
|
|
00004-0245-15
|
6505-01-434-7725
|
Saquinavir Mesylate Capsules |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-0245-15
|
6505-01-434-7725
|
Saquinavir Mesylate Capsules |
Roche Laboratories Inc.
|
|
Quote
|
|
INVIRASE
|
6505-01-434-7725
|
Saquinavir Mesylate Capsules |
Roche Laboratories Inc
|
|
Quote
|
|
NDC00004-0245-15
|
6505-01-434-7725
|
Saquinavir Mesylate Capsules |
Roche Laboratories Inc
|
|
Quote
|
|
NDC00703-2859-03
|
6505-01-434-8619
|
Propofol Injection |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC63323-0269-65
|
6505-01-434-8619
|
Propofol Injection |
Fresenius Kabi Usa Llc
|
|
Quote
|
|
NDC63323-0270-65
|
6505-01-434-8619
|
Propofol Injection |
Fresenius Kabi Usa Llc
|
|
Quote
|
|
DIPRIVAN
|
6505-01-434-8619
|
Propofol Injection |
Fresenius Kabi Usa Llc
|
|
Quote
|
|
DIPRIVAN
|
6505-01-434-8619
|
Propofol Injection |
App Pharmaceuticals Inc.
|
|
Quote
|
|
NDC63323-0269-65
|
6505-01-434-8619
|
Propofol Injection |
App Pharmaceuticals Inc.
|
|
Quote
|
|
NDC63323-0270-65
|
6505-01-434-8619
|
Propofol Injection |
App Pharmaceuticals Inc.
|
|
Quote
|
|
96-0496
|
6505-01-434-8622
|
Propofol Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC00703-2858-09
|
6505-01-434-8622
|
Propofol Injection |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC00409-4699-33
|
6505-01-434-8622
|
Propofol Injection |
Hospira, Inc.
|
|
Quote
|
|
NDC63323-0269-50
|
6505-01-434-8622
|
Propofol Injection |
Fresenius Kabi Usa Llc
|
|
Quote
|
|
NDC63323-0269-50
|
6505-01-434-8622
|
Propofol Injection |
App Pharmaceuticals Inc.
|
|
Quote
|
